BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18357801)

  • 1. Influence of oral contraceptive use on the risk of adult-onset vulvodynia.
    Harlow BL; Vitonis AF; Stewart EG
    J Reprod Med; 2008 Feb; 53(2):102-10. PubMed ID: 18357801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult-onset vulvodynia in relation to childhood violence victimization.
    Harlow BL; Stewart EG
    Am J Epidemiol; 2005 May; 161(9):871-80. PubMed ID: 15840620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of dietary oxalates on the risk of adult-onset vulvodynia.
    Harlow BL; Abenhaim HA; Vitonis AF; Harnack L
    J Reprod Med; 2008 Mar; 53(3):171-8. PubMed ID: 18441720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urogenital infections in relation to the occurrence of vulvodynia.
    Nguyen RH; Swanson D; Harlow BL
    J Reprod Med; 2009 Jun; 54(6):385-92. PubMed ID: 19639929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study.
    Lee E; Ma H; McKean-Cowdin R; Van Den Berg D; Bernstein L; Henderson BE; Ursin G
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3170-8. PubMed ID: 18990759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogens and the risk of complex regional pain syndrome (CRPS).
    de Mos M; Huygen FJ; Stricker BH; Dieleman JP; Sturkenboom MC
    Pharmacoepidemiol Drug Saf; 2009 Jan; 18(1):44-52. PubMed ID: 19111016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the reliability and validity of physician ratings for vulvodynia and the discriminant validity of its subtypes.
    Masheb RM; Lozano C; Richman S; Minkin MJ; Kerns RD
    Pain Med; 2004 Dec; 5(4):349-58. PubMed ID: 15563320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cigarette smoking and risk of cerebral sinus thrombosis in oral contraceptive users: a case-control study.
    Ciccone A; Gatti A; Melis M; Cossu G; Boncoraglio G; Carriero MR; Iurlaro S; Agostoni E
    Neurol Sci; 2005 Dec; 26(5):319-23. PubMed ID: 16388365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vulvodynia incidence and remission rates among adult women: a 2-year follow-up study.
    Reed BD; Haefner HK; Sen A; Gorenflo DW
    Obstet Gynecol; 2008 Aug; 112(2 Pt 1):231-7. PubMed ID: 18669716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vulvodynia. Development of a psychosexual profile.
    Jantos M; Burns NR
    J Reprod Med; 2007 Jan; 52(1):63-71. PubMed ID: 17286072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective study of relevant diagnostic procedures in vulvodynia.
    Petersen CD; Kristensen E; Lundvall L; Giraldi A
    J Reprod Med; 2009 May; 54(5):281-7. PubMed ID: 19517691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chest pain among oral contraceptive users.
    Williams K
    J R Coll Gen Pract; 1980 Jan; 30(210):33-4. PubMed ID: 7373575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of vulvodynia with tricyclic antidepressants: efficacy and associated factors.
    Reed BD; Caron AM; Gorenflo DW; Haefner HK
    J Low Genit Tract Dis; 2006 Oct; 10(4):245-51. PubMed ID: 17012991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oral contraceptives on risk of cervical cancer.
    Vanakankovit N; Taneepanichskul S
    J Med Assoc Thai; 2008 Jan; 91(1):7-12. PubMed ID: 18386537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.
    Morin-Papunen L; Martikainen H; McCarthy MI; Franks S; Sovio U; Hartikainen AL; Ruokonen A; Leinonen M; Laitinen J; Järvelin MR; Pouta A
    Am J Obstet Gynecol; 2008 Nov; 199(5):529.e1-529.e10. PubMed ID: 18533124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability and validity of self-reported symptoms for predicting vulvodynia.
    Reed BD; Haefner HK; Harlow SD; Gorenflo DW; Sen A
    Obstet Gynecol; 2006 Oct; 108(4):906-13. PubMed ID: 17012453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative sensory testing in vulvodynia patients and increased peripheral pressure pain sensitivity.
    Giesecke J; Reed BD; Haefner HK; Giesecke T; Clauw DJ; Gracely RH
    Obstet Gynecol; 2004 Jul; 104(1):126-33. PubMed ID: 15229011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism in women using hormonal contraceptives. Findings from the RIETE Registry.
    Blanco-Molina A; Trujillo-Santos J; Tirado R; Cañas I; Riera A; Valdés M; Monreal M;
    Thromb Haemost; 2009 Mar; 101(3):478-82. PubMed ID: 19277408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraception, body mass index, and asthma: a cross-sectional Nordic-Baltic population survey.
    Macsali F; Real FG; Omenaas ER; Bjorge L; Janson C; Franklin K; Svanes C
    J Allergy Clin Immunol; 2009 Feb; 123(2):391-7. PubMed ID: 19121863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of third-generation oral contraceptives on high-sensitivity C-reactive protein and homocysteine in young women.
    Cauci S; Di Santolo M; Culhane JF; Stel G; Gonano F; Guaschino S
    Obstet Gynecol; 2008 Apr; 111(4):857-64. PubMed ID: 18378744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.